icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2021
Back grey_arrow_rt.gif
 
 
 
Pentavalent HCV Vaccine Candidate Elicits Broadly Neutralizing Antibodies to Neutralization-Resistant Variants
 
 
  AASLD 2021 Nov 12-15
 
There is a need for a vaccine. The challenge of past vaccine approaches has been virus diversity. Here is a new approach to vaccine development targeting the hypervariable region of HCV. Here is the data with the inhibition of viral entry in the HCVpp across genotypes 1-6. Although perhaps promising there is still a long way to go.
 
Alexander I. Mosa 1, D.S. Campo2, Richard A. Urbanowicz 3, Adam J. Gehring 1, Mounir G. AbouHaidar 4, John E. Tavis 5, Jonathan K. Ball 3, and Jordan J. Feld 1.

1130211

1130212

1130213

1130214

1130215

1130216

1130217

1130218

1130219

11302110

11302111

11302112